TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11735135

Group type: COMPARATOR
Intervention: Local anaesthesia
Number of subjects: 435

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 435

Group type: COMPARATOR
Intervention: General anaesthesia (unilateral procedures)
Number of subjects: 435
Study: 9425967

Group type: EXPERIMENTAL
Intervention: 27-gauge Quincke type needle
Number of subjects: 400

Group type: COMPARATOR
Intervention: 27-gauge pencil-point needle
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Overall incidence of postdural puncture headache
Number of subjects: 400
Study: 8276300

Group type: EXPERIMENTAL
Intervention: External irradiation combined with intraperitoneal instillation of radioactive gold (198Au)
Number of subjects: 253

Group type: COMPARATOR
Intervention: External irradiation alone
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Intraperitoneal radioactive therapy followed by thio-TEPA
Number of subjects: 253

Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Thio-TEPA
Number of subjects: 253

Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 253

Group type: COMPARATOR
Intervention: 32P treatment
Number of subjects: 253
Study: 3320784

Group type: EXPERIMENTAL
Intervention: bendrofluazide
Number of subjects: 17354

Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 17354

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17354
Study: 31083170

Group type: EXPERIMENTAL
Intervention: Community-based intervention program (6 sessions, once weekly)
Number of subjects: 160
Study: 28089730

Group type: EXPERIMENTAL
Intervention: Chronic inflammation
Number of subjects: 4099

Group type: EXPERIMENTAL
Intervention: Acute inflammation
Number of subjects: 4099

Group type: COMPARATOR
Intervention: No intervention (placebo group)
Number of subjects: 4099
Study: 24685604

Group type: EXPERIMENTAL
Intervention: Home-based high frequency exercise (HFE) - aerobic exercise at 70% of max for 30 minutes, five times/week and resistance exercise three times/week for eight weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group - usual lifestyle
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Home-based high frequency exercise (HFE)
Number of subjects: 62
Study: 23625331

Group type: EXPERIMENTAL
Intervention: Evening primrose oil (500 mg, 2 capsules per day for 6 weeks)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (2 capsules per day for 6 weeks)
Number of subjects: 56
Study: 22212765

Group type: EXPERIMENTAL
Intervention: Intervention group (n=33) received weekly topic-based reading instructions and five telephone consultations with an audiologist.
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (n=36) read the same book but did not have discussions with a professional.
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Intervention group (n=33)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (n=36)
Number of subjects: 69
Study: 19501610

Group type: EXPERIMENTAL
Intervention: Horizontal grating patterns as targets with vertical suppressor bars
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inclusion of a spatial gap between vertical suppressors and the target
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Luminance variation along the target
Number of subjects: 0
Study: 16418085

Group type: EXPERIMENTAL
Intervention: Rapid-sequence intubation (RSI) with etomidate (0.3 mg/kg) and succinylcholine (1.5 mg/kg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Etomidate-only intubation (EOI) with etomidate (0.3 mg/kg)
Number of subjects: 49
Study: 12690269

Group type: EXPERIMENTAL
Intervention: Early insertion of tympanostomy tubes
Number of subjects: 429

Group type: COMPARATOR
Intervention: Delayed insertion of tympanostomy tubes (up to 9 months later)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of children with bilateral, continuous MEE
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of children with the greatest degrees of hearing loss
Number of subjects: 429
Study: 11090788

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/benazepril 10 mg
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/benazepril 20 mg
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Nifedipine 60 mg
Number of subjects: 1079

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 1079

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 1079

Group type: COMPARATOR
Intervention: Low-dose calcium antagonists
Number of subjects: 1079
Study: 8815943

Group type: EXPERIMENTAL
Intervention: Coronary angiography
Number of subjects: 21772

Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 21772

Group type: EXPERIMENTAL
Intervention: Age < 73 years
Number of subjects: 21772

Group type: EXPERIMENTAL
Intervention: Age ≥ 73 years
Number of subjects: 21772

Group type: EXPERIMENTAL
Intervention: Availability of angioplasty
Number of subjects: 21772

Group type: EXPERIMENTAL
Intervention: Recurrent ischemia
Number of subjects: 21772

Group type: EXPERIMENTAL
Intervention: Coronary anatomy
Number of subjects: 21772
Study: 1592777

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 3985104

Group type: EXPERIMENTAL
Intervention: New styrene-type gas-permeable hard (GPH) lens
Number of subjects: 10

Group type: COMPARATOR
Intervention: Other GPH lenses and some soft lenses
Number of subjects: 10
Study: 29724196

Group type: EXPERIMENTAL
Intervention: Keeping Safe programme (intervention group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wait-list control group (control group)
Number of subjects: 80
Study: 26898481

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Peginterferon (PEG‐IFN) add-on
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: HBcrAg
Number of subjects: 175
Study: 24353344

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamin E, 400 IU; vitamin C, 500 mg; selenium, 50 μg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 23213946

Group type: EXPERIMENTAL
Intervention: Vitamins A, C, and E intake (both natural and supplementary)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Healthy examinees (control group)
Number of subjects: 180
Study: 20491360

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg daily
Number of subjects: 5926

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5926
Study: 17980503

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Zinc supplementation in patients with Stages III-IV disease
Number of subjects: 100
Study: 16208784

Group type: EXPERIMENTAL
Intervention: 5 ml bupivacaine 0.25% into the margin
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 5 ml bupivacaine 0.25% into the cavity
Number of subjects: 27

Group type: COMPARATOR
Intervention: 5 ml physiological saline into the cavity
Number of subjects: 27
Study: 11835037

Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Trandolapril 0.5 mg
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 12523874

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 9548163

Group type: EXPERIMENTAL
Intervention: Implanon
Number of subjects: 32

Group type: COMPARATOR
Intervention: Norplant
Number of subjects: 32
Study: 8040991

Group type: EXPERIMENTAL
Intervention: Repair of incisional hernia using synthetic mesh
Number of subjects: 55

Group type: COMPARATOR
Intervention: Simple repair of incisional hernia
Number of subjects: 55
Study: 2837105

Group type: EXPERIMENTAL
Intervention: Ethanol (0.42 g/kg) + marihuana (2.4% THC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) + marihuana (2.4% THC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Placebo ethanol + marihuana (2.4% THC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low dose ethanol (0.42 g/kg) + placebo marihuana
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: High dose ethanol (0.85 g/kg) + placebo marihuana
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo ethanol + placebo marihuana
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low dose ethanol (0.42 g/kg) + marihuana (2.4% THC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: High dose ethanol (0.85 g/kg) + marihuana (2.4% THC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (0.42 g/kg) + marihuana (0.0004% THC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) + marihuana (0.0004% THC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Placebo ethanol + marihuana (0.0004% THC)
Number of subjects: 6
Study: 31421990

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA) paired with active MBM (20 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS paired with sham MBM
Number of subjects: 30
Study: 29173603

Group type: EXPERIMENTAL
Intervention: Omron HEM 907 in closed areas
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Omron HEM 907 in open areas
Number of subjects: 258

Group type: COMPARATOR
Intervention: BpTRU
Number of subjects: 258
Study: 26562605

Group type: EXPERIMENTAL
Intervention: General anxiety sensitivity (AS) factor
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Cognitive, physical, and social concerns subfactors of AS
Number of subjects: 329
Study: 24021419

Group type: EXPERIMENTAL
Intervention: Teen CHAT online educational intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study: 21680702

Group type: EXPERIMENTAL
Intervention: SRT501 (micronized resveratrol) 5.0 g daily for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRT501 (micronized resveratrol)
Number of subjects: 0
Study: 18459077

Group type: EXPERIMENTAL
Intervention: Transoral Gastroplasty (TOGA) system
Number of subjects: 11
Study: 16796856

Group type: EXPERIMENTAL
Intervention: Cardiac sympathetic blockade (TEB)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 14555261

Group type: EXPERIMENTAL
Intervention: Clodronate (100 mg im/week) plus calcium (1000 mg) and vitamin D (800 UI)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Calcium (1000 mg) and vitamin D (800 UI) alone
Number of subjects: 163
Study: 11087879

Group type: EXPERIMENTAL
Intervention: Hip protector
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Hip protector (while wearing)
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Hip protector (while not wearing)
Number of subjects: 1801
Study: 8741720

Group type: EXPERIMENTAL
Intervention: Cognitive therapy targeted specifically on the single symptom of their delusional belief(s)
Number of subjects: 6
Study: 1565419

Group type: EXPERIMENTAL
Intervention: Rigid gas-permeable contact lens extended wear (EWRGP)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Soft lens extended wear (SLEW)
Number of subjects: 88

Group type: COMPARATOR
Intervention: RGP daily wear (DWRGP)
Number of subjects: 88
Study: 31685212

Group type: EXPERIMENTAL
Intervention: Gemcabene 300 mg for 4 weeks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Gemcabene 600 mg for 4 weeks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Gemcabene 900 mg for 4 weeks
Number of subjects: 8
Study: 29767677

Group type: EXPERIMENTAL
Intervention: docetaxel + bavituximab 3 mg/kg
Number of subjects: 597

Group type: COMPARATOR
Intervention: docetaxel + placebo
Number of subjects: 597
Study: 27450686

Group type: EXPERIMENTAL
Intervention: guided iCBT‐I
Number of subjects: 128

Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 128
Study: 23625982

Group type: EXPERIMENTAL
Intervention: 20 mg prednisolone
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 50 mg prednisolone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 23044285

Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 or 30 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19996767

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 17636226

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 16195034

Group type: EXPERIMENTAL
Intervention: Moderate intermittent physical exercise (exercised group)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Light work in the barracks (non-exercised control group)
Number of subjects: 57
Study: 12012138

Group type: EXPERIMENTAL
Intervention: diclofenac-colestyramine
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study: 10393997

Group type: EXPERIMENTAL
Intervention: Pacifier with sucrose
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pacifier with water
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 25
Study: 7557813

Group type: EXPERIMENTAL
Intervention: Amitriptyline 30 mg/d
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flupentixol 1.5 mg/d
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Clotiazepam 15 mg/d
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All drugs compared
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meta-analysis of chronic GAD
Number of subjects: 30
Study: 2149728

Group type: EXPERIMENTAL
Intervention: Amitriptyline + lithium
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lithium alone
Number of subjects: 40
Study: 7235102

Group type: EXPERIMENTAL
Intervention: Experimental group (personal contact added to standard treatment)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (notification to parents by a form letter)
Number of subjects: 124
Study: 31445061

Group type: EXPERIMENTAL
Intervention: anodal tDCS + exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: sham stimulation + exercise
Number of subjects: 15
Study: 27887820

Group type: EXPERIMENTAL
Intervention: TVD group (with real-time tidal volume feedback)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (without tidal volume feedback)
Number of subjects: 14
Study: 26994359

Group type: EXPERIMENTAL
Intervention: Oil in Baby SkincaRE (OBSeRvE) intervention
Number of subjects: 115

Group type: COMPARATOR
Intervention: No oil control group
Number of subjects: 115
Study: 24908596

Group type: EXPERIMENTAL
Intervention: 2% miconazole
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2% Uncaria tomentosa gel
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22011667

Group type: EXPERIMENTAL
Intervention: Palifermin
Number of subjects: 95
Study: 19755647

Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 979

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 979
Study: 17186282

Group type: EXPERIMENTAL
Intervention: Graded Activity (GA) intervention
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 134
Study: 15319379

Group type: EXPERIMENTAL
Intervention: NuvaRing
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (COC)
Number of subjects: 40
Study: 11451620

Group type: EXPERIMENTAL
Intervention: Oestrogen only (Estraderm TTS 50) (n=6)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transdermal oestrogen and progesterone (Estraderm TTS 50 and 0.4 mg progesterone vaginal suppository) (n=7)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral oestrogen and progesterone (2 mg Progynova and 0.4 mg progesterone vaginal suppository) (n=8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n=3)
Number of subjects: 24
Study: 9509747

Group type: EXPERIMENTAL
Intervention: Pupil noise amplitude measurement in narcoleptics
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pupil noise amplitude measurement in controls
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Statistical classification of subjects
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypothesis testing for class membership
Number of subjects: 20
Study: 8066557

Group type: EXPERIMENTAL
Intervention: Inhaled acetaldehyde (0.8 mg/ml for 4 minutes)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inhaled acetaldehyde with terfenadine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Oral placebo and inhaled saline
Number of subjects: 9
Study: 2848786

Group type: EXPERIMENTAL
Intervention: levamisole (2.5 mg/kg twice weekly for 2 years or until tumor progression)
Number of subjects: 285

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 285
Study: 31802541

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine effect-site concentration (Ce)
Number of subjects: 45
Study: 31144584

Group type: EXPERIMENTAL
Intervention: Selection strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rejection strategy
Number of subjects: 0
Study: 28539066

Group type: EXPERIMENTAL
Intervention: Water-based treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Land-based treatment
Number of subjects: 36
Study: 26062180

Group type: EXPERIMENTAL
Intervention: Electroacupuncture applied to bilateral Fushe (SP 13) and Shuidao (ST 28); 2 Hz/50 Hz, retaining for 30 min, one treatment
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 154

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 154
Study: 24183981

Group type: EXPERIMENTAL
Intervention: delNS1‐trivalent vaccine at 7.0log10 TCID50/subject
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22048110

Group type: EXPERIMENTAL
Intervention: Zoster vaccine (ZV)
Number of subjects: 11980

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11980
Study: 19185236

Group type: EXPERIMENTAL
Intervention: Coaxial clear corneal microincision cataract surgery (MICS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Coaxial small‐incision cataract surgery (SICS)
Number of subjects: 60
Study: 18167249

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy combined with intraoperative endoscopic sphincterotomy (LC-IOEST)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy combined with laparoscopic common bile duct exploration (LC-LCBDE)
Number of subjects: 275
Study: 16353407

Group type: EXPERIMENTAL
Intervention: Whole-body MRI
Number of subjects: 21
Study: 12379622

Group type: EXPERIMENTAL
Intervention: Anti-TNF monoclonal antibody infliximab
Number of subjects: 80

Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 80
Study: 9579768

Group type: EXPERIMENTAL
Intervention: Quinapril (ACE inhibitor)
Number of subjects: 0
Study: 7543956

Group type: EXPERIMENTAL
Intervention: rG.CSF (5 micrograms/kg/d d.i.v.)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 2651489

Group type: EXPERIMENTAL
Intervention: Alprazolam, 0.5-6.0 mg/day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Adinazolam mesylate, 10-120 mg/day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (baseline condition)
Number of subjects: 14
Study: 21116

Group type: EXPERIMENTAL
Intervention: Fluphenazine/nortriptyline (specific antidepressant together with an anxiolytic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Potassium clorazepate (pure anxiolytic)
Number of subjects: 0
Study: 30462182

Group type: EXPERIMENTAL
Intervention: Colistin monotherapy
Number of subjects: 266

Group type: COMPARATOR
Intervention: Colistin-meropenem combination therapy
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Colistin resistant (CoR) isolates
Number of subjects: 266

Group type: COMPARATOR
Intervention: Colistin susceptible (CoS) isolates
Number of subjects: 266
Study: 28244612

Group type: EXPERIMENTAL
Intervention: Green tea tablets
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 24970794

Group type: EXPERIMENTAL
Intervention: Uninterrupted oral anticoagulation (UAC)
Number of subjects: 573

Group type: COMPARATOR
Intervention: Bridging therapy (BT)
Number of subjects: 573
Study: 24262616

Group type: EXPERIMENTAL
Intervention: Crush stenting
Number of subjects: 424

Group type: COMPARATOR
Intervention: Culotte stenting
Number of subjects: 424
Study: 21941091

Group type: EXPERIMENTAL
Intervention: ZOSTAVAX (refrigerator-stable formulation), single dose administered within 6 months of expiry
Number of subjects: 2
Study: 19888523

Group type: EXPERIMENTAL
Intervention: Subcutaneous unfractionated heparin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravenous unfractionated heparin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 15
Study: 16520474

Group type: EXPERIMENTAL
Intervention: Chloroquine (150 mg/d for 12 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15486520

Group type: EXPERIMENTAL
Intervention: Milnacipran 75 mg daily
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Milnacipran 150 mg daily
Number of subjects: 66
Study: 10202747

Group type: EXPERIMENTAL
Intervention: Amino-Cerv intravaginally for two weeks after LEEP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Untreated group (Control)
Number of subjects: 48
Study: 7799026

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP) 750 mg orally twice per day
Number of subjects: 146

Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole (TMS) 160 mg trimethoprim and 800 mg sulfamethoxazole orally twice per day
Number of subjects: 146

Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole (TMS)
Number of subjects: 146
Study: 2191113

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 87620

Group type: EXPERIMENTAL
Intervention: Apomorphine combined with domeperidone (peripheral dopamine receptor blocker)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4